Lung metastases have been found in 25-30% of all patients with cancer at au
topsy. Those patients satisfying criteria for surgical resection represent
a much smaller subgroup.
Given the potentially curative nature of pulmonary metastasectomy in the ab
sence of disseminated disease, it has become widely accepted as an importan
t treatment option for a variety of malignancies with metastasis to the lun
gs. A standardized approach remains unfounded however, given limited number
s of patients, various histologic subtypes and few published studies utiliz
ing randomized prospective methodology.
Ultimately, the development of metastasis represents a major determinant of
survival for patients with cancer. Pulmonary metastasectomy is an importan
t treatment modality for patients with metastatic pulmonary disease. The in
dications for pulmonary metastasectomy and the surgeon's role in pulmonary
metastatic disease continue to evolve. Future prospective studies and the c
ompilation of comparable data yielding prognostic factors for specific hist
ologies will better define indications for resection. (C) 2001 Elsevier Sci
ence Ltd. All rights reserved.